Alerts

• NEW: A Call to Action for the COVID-19 Response: How to Restore Your Inactive, Retired, or Cancelled Medical License to Full, Active Status
  
• NEW: COVID19 Response - Temporary CME Waiver for License Renewal
  
• NEW: California Health Corps - How Health Professionals Can Help During COVID-19
  
• NEW: Medical Board of California Closes Public Front Counter
  
  The Medical Board remains open as we perform essential governmental functions to license and regulate physicians and surgeons and other allied health care professionals on the front lines of the Coronavirus (COVID-19) pandemic. However, in the interest of adhering to social distancing protocols to prevent the spread of COVID-19, the Board’s office is closed to the public until further notice. Should you experience any delays in reaching staff during this time, we appreciate your patience and apologize for any inconvenience in advance.
  Please contact the Board by email: webmaster@mbc.ca.gov, telephone: 800-633-2322 or U.S. Mail: 2005 Evergreen Street, Suite 1200, Sacramento, CA 95815.
• NEW: Notice Regarding Service of Process on the Medical Board of California
  
  Effective immediately and until further notice, as a result of measures taken to limit the spread or exposure of COVID-19, the Medical Board of California will accept service of process by mail in accordance with C.C.P. section 415.30.
  Medical Board of California
  Attn: David Ruswinkle
  2005 Evergreen Street, Ste. 1200
  Sacramento, CA 95815-5401
  If you have any questions, please contact our offices by email at webmaster@mbc.ca.gov, or phone at 800-633-2322.
• NEW: EMSA Information for California and out-of-state health care providers regarding Coronavirus Disease 2019 (COVID-19)
• NEW: CDPH What You Need To Know: Novel Coronavirus 2019 (COVID-19)
• UPDATED: Fake Board Representative/DEA Agents Extortion Scam
• HHS Announces Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use
• Controlled Substance Prescription Form Serial Number Data Submission
• Statewide Opioid Safety Workgroup Alert - Don’t Drop Your Patients
• Statewide Opioid Safety Workgroup Alert - Responding to a Fentanyl Overdose: What CA First Responders Need to Know
• FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables
• FDA warns compounders not to use glutathione from Letco Medical to compound sterile drugs
• FDA Alerts Consumers About Potentially Life-Threatening Health Problems Linked to Limbrel
• Are Your Prescription Forms Compliant?